Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bial
Biotech
EuroBiotech: More Articles of Note
In our EuroBiotech roundup this week, Actelion reveals financial details of spinout, Novo A/S invests in Evotec and BIAL offloads Parkinson’s drug rights.
Nick Paul Taylor
Feb 16, 2017 9:22am
EMA updates first-in-human trial guidance
Nov 16, 2016 12:10pm
French prosecutors to investigate manslaughter charge over fatal trial
Jun 14, 2016 6:36am
EMA to hold major review after fatal French trial
May 24, 2016 6:35am
EuroBiotech: More Articles of Note
Apr 21, 2016 9:06am
‘Toxic compound’ gains final blame in French trial disaster
Apr 21, 2016 3:58am
